Brooklyn Immunotherapeutics IncBrooklyn Immunotherapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Movies & Entertainment

Check the end of this webpage for potential risks for Brooklyn Immunotherapeutics Inc based on sector, geography and marketcap. The report of Brooklyn Immunotherapeutics Inc uses data from across the internet as well as from public disclosures by Brooklyn Immunotherapeutics Inc. Complete ESG analysis of Brooklyn Immunotherapeutics Inc can be accessed by signing up for free.

Brooklyn Immunotherapeutics Inc in the Movies & Entertainment industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 0.0, social score of 3.4 and governance score of 3.0.

SDG Transparency Score for Brooklyn Immunotherapeutics Inc 

2.1

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Brooklyn Immunotherapeutics Inc 
0.0

Environmental

3.4

Social

3.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Event Hospitality and Entertainment Ltd
8.2
High
2Balaji Telefilms Ltd
8.0
High
.........
203Starrise Media Holdings Ltd
2.2
Medium
203Qatar Cinema and Film Distribution Co QPSC
2.2
Medium
209Brooklyn Immunotherapeutics Inc
2.1
Medium
209FreeCast Inc
2.1
Medium
209Universal Arts Ltd
2.1
Medium
.........
336Valiant Eagle Inc
0.0
Low
336m4e AG
0.0
Low
.........
View the full peer group of 413 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Brooklyn Immunotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Brooklyn Immunotherapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Brooklyn Immunotherapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Brooklyn Immunotherapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Brooklyn Immunotherapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Brooklyn Immunotherapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Brooklyn Immunotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Sorry!

Failed to process!